Position in ELAN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$424,522
+$11,730 QoQ
Shares Held
17,250
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#295
of 515 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRAXIS INVESTMENT MANAGEMENT INC holds $2,979,923 across 8 Drug Manufacturers - Specialty & Generic names. ELAN ranks #3 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,380 | $747,725 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
3,074 | $518,091 | |
| 3 | ELAN |
Elanco Animal Health Inc
This page
|
17,250 | $424,522 | |
| 4 | ALKS |
Alkermes plc.
|
5,798 | $303,815 | |
| 5 | ZTS |
Zoetis Inc.
|
3,822 | $274,648 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
7,659 | $265,537 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
2,141 | $237,522 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
5,071 | $208,063 |
All Filings in ELAN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $424,522 | 17,250 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $412,792 | 17,250 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $390,367 | 17,250 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $347,415 | 17,250 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $246,330 | 17,250 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $181,125 | 17,250 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $208,897 | 17,250 | Shares | Sole | 2025-01-03 | |
| No filing history on record for this holder in this stock. | ||||||